Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Revising the 'textbook' on liver metabolism offers new targets for diabetes drugs

22.02.2012
A team led by researchers from the Institute for Diabetes, Obesity and Metabolism (IDOM) at the Perelman School of Medicine, University of Pennsylvania, has overturned a "textbook" view of what the body does after a meal. The study appears online this week in Nature Medicine, in advance of print publication.
Normally after a meal, insulin shuts off glucose production in the liver, but insulin resistance – when the hormone becomes less effective at lowering blood sugars – can become a problem.

The Penn group showed that mice without the genes Akt1 and Akt2 in their livers were insulin resistant and defective in their response to feeding with respect to blood sugar levels. In these mice, blood sugar levels remained high after a meal. When Akt is not present, another gene, Foxo, is on all the time, and the liver "thinks" the body is fasting. In response, glucose production stays on to keep cells supplied in energy-rich molecules.

But then, says senior author Morris Birnbaum, MD, PhD, professor of medicine and IDOM Associate Director, "In further experiments, we expected that Akt and Foxo knockout mice – when we gave them a meal – to be locked into a fed state metabolically if both proteins were gone," says Birnbaum. "But, the liver responded normally after a meal, so we asked what is regulating the liver and glucose production in the absence of both the Akt and Foxo proteins?"

These results are inconsistent with the textbook model of liver metabolism that the Birnbaum lab proposed a decade ago, in which the Akt protein is absolutely required for proper insulin signaling. The team surmised that there must be a backup pathway in the liver that governs glucose metabolism.

Back Then
Ten years ago, a study in Science by Birnbaum's research group described that the inactivation of the protein Akt2 led to diabetes in mice. The result was that insulin was not working in the fat cells and liver of these mice,
proving that Akt is required for insulin to function properly. From then on, an accepted pathway for insulin control of blood sugar was that the Akt protein turned off Foxo1, a protein that governs genes that make glucose. Specifically, when Foxo1 is on, it drives glucose production. After a meal, Akt modifies Foxo1 so that it reduces Foxo1's activity. This turns off glucose production, so blood sugar levels stay within a safe range after eating.

"When we started our present experiments to see how this pathway might apply to other aspects of metabolic regulation, this scenario is what we expected to see, based on the literature," notes Birnbaum.

Backup Systems
Why would animals need a seemingly redundant pathway? The scenario that the researchers favor is that insulin is working on other tissues' receptors and also communicates with the liver before and after a meal. The candidate organ is the brain via the nervous system. Studies by other labs have shown there are insulin receptors in the brain and suggested such a pathway may exist, though many scientists have been hesitant to accept this notion due to conflicting data, says Birnbaum.

However, the new results from the Birnbaum lab provide an explanation of why it has been difficult to see the backup pathway: When insulin signaling in the liver is disrupted, the organ loses its ability to respond to outside signals.

The team surmises that the normal state for the body is that Foxo is off most of the time, but during a diabetic state, Foxo is inappropriately activated. And when Foxo is on, which they propose is not the normal state, the liver is prevented from responding to the brain's signal to stop or start glucose production. The team is now working on testing this hypothesis.

In the short run, these results suggest several other pathways to target in the hope to bypass the block in insulin action that occurs in Type 2 diabetes. First, one could try to mimic the signal external to the liver. Second, it might be possible to develop therapies that allow the liver to respond to signals from such other organs as the brain, even though usually during diabetes the active Foxo1 prevents this.

Co-authors on the study include lead author Mingjian Lu, as well as Min Wan, Karla F Leavens, Qingwei Chu, Bobby R Monks, Sully Fernandez, and Rex Ahima, all from Penn. Kohjiro Ueki and C, Ronald Kahn from the University of Tokyo and Joslin Diabetes Center, respectively, were also co-authors.

The Functional Genomics Core and the Transgenic, Knockout, Mouse Phenotyping and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525), in part, funded the research. This work was also supported by the NIH grant RO1 DK56886 and the diabetes training grant T32 DK007314.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4 billion enterprise.

Penn's Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools and among the top 10 schools for primary care. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $507.6 million awarded in the 2010 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2010, Penn Medicine provided $788 million to benefit our community.

Karen Kreeger | EurekAlert!
Further information:
http://www.uphs.upenn.edu

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>